Caplin Point Laboratories Quarterly Results

Latest Quarter Net Profit
₹182 Cr
QSept 2026
Quarterly Results

Caplin Point Laboratories quarterly results. In Sept 2026, Caplin Point Laboratories (CAPLIPOINT) reported revenue ₹663 Cr and net profit ₹182 Cr — revenue +17.6% YoY. View CAPLIPOINT price range for the annual high/low range and current price position.

CAPLIPOINT Quarterly Results — Revenue, Profit & EPS Highlights

Caplin Point Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore CAPLIPOINT share price history to track price trends across different timeframes.

  • Revenue of ₹663 Cr in Sept 2026 (+5.4% vs Mar 2026, +17.6% vs Sept 2025)
  • Net Profit of ₹182 Cr in Sept 2026 (+5.2% vs Mar 2026, +13.8% vs Sept 2025)
  • EBITDA of ₹257 Cr in Sept 2026 (+10.3% vs Mar 2026)
  • Operating Margin of 35.0% in Sept 2026 (+1.0pp vs Mar 2026)
  • Earnings Per Share of ₹23.44 in Sept 2026 (+4.7% vs Mar 2026)

Caplin Point Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

CAPLIPOINT quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 663 629 644 564 528 5.4% 17.6%
Net Profit (₹ Cr) 182 173 179 160 145 - -
EBITDA (₹ Cr) 257 233 247 220 194 - -
EPS (₹) 23.44 22.38 23.27 20.32 18.75 - -
Operating Margin (%) 35.0% 34.0% 35.0% 35.0% 33.0% - -

CAPLIPOINT Share Price Trend — 1-Year Movement Across Quarterly Results

Caplin Point Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Caplin Point Laboratories share price today.

Profitability Ratios

Profit Margin 27.5%
EBITDA Margin 38.8%
Operating Margin 35.0%
ROE (Annual) 20.0%

Balance Sheet Highlights

Total Assets ₹4,046 Cr
Total Equity ₹3,631 Cr
Current Assets ₹ Cr
Current Liabilities ₹29 Cr

Cash Flow Analysis

Operating Cash Flow ₹523 Cr
Investing Cash Flow ₹-582 Cr
Financing Cash Flow ₹-47 Cr
Net Cash Flow ₹-105 Cr

Current Market Data

Current Price ₹2084.60
Exchange NSE
Last Updated Nov 19, 2026

CAPLIPOINT vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Caplin Point Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores